Literature DB >> 18369062

The effect of sildenafil on ocular blood flow.

A Harris1, L Kagemann, R Ehrlich, Y Ehrlich, C R López, V A Purvin.   

Abstract

Sildenafil is a potent phosphodiesterase (PDE) 5 inhibitor that is used for patients with erectile dysfunction. Sildenafil induces vasodilation in selected smooth muscle via increased levels of guanosine 3', 5' cyclic monophosphate and increase in nitric oxide. The vasodilatory effects of the PDE 5 inhibitors led us to review its effect on the ocular vasculature. Sildenafil appears to increase blood flow velocity significantly in the retrobulbar and choroidal circulation. Most studies suggest an increase in choroidal blood flow, with a lesser effect on the retinal vasculature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18369062     DOI: 10.1136/bjo.2007.131789

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  21 in total

Review 1.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

2.  Sildenafil accelerates anterior chamber refilling after paracentesis in sheep and rabbits.

Authors:  Rosana Gerometta; Lawrence J Alvarez; Oscar A Candia
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-01       Impact factor: 4.799

3.  Effect of sildenafil citrate on intraocular pressure and blood pressure in human volunteers.

Authors:  Rosana Gerometta; Lawrence J Alvarez; Oscar A Candia
Journal:  Exp Eye Res       Date:  2011-05-30       Impact factor: 3.467

4.  Measurement of choroidal perfusion and thickness following systemic sildenafil (Viagra(®) ).

Authors:  David Y Kim; Ronald H Silverman; Robison Vernon Paul Chan; Aziz A Khanifar; Mark Rondeau; Harriet Lloyd; Peter Schlegel; Donald Jackson Coleman
Journal:  Acta Ophthalmol       Date:  2012-09-13       Impact factor: 3.761

5.  [Acute unilateral loss of vision in a 38-year-old male patient].

Authors:  E Papageorgiou; Z Gatzioufas; K Ninios; B Seitz
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

6.  Effects of sildenafil and tadalafil on intraocular pressure in sheep: implications for aqueous humor dynamics.

Authors:  Rosana Gerometta; Lawrence J Alvarez; Oscar A Candia
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

7.  Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity.

Authors:  Amani A Fawzi; Jonathan C Chou; Gina A Kim; Stuart D Rollins; Joann M Taylor; Kathryn N Farrow
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-10       Impact factor: 4.799

8.  Acute onset of bilateral visual loss during sildenafil therapy in a young infant with congenital heart disease.

Authors:  Marcella Gaffuri; Alessandra Cristofaletti; Caterina Mansoldo; Paolo Biban
Journal:  BMJ Case Rep       Date:  2014-06-03

9.  Sildenafil stimulates aqueous humor turnover in rabbits.

Authors:  Lawrence J Alvarez; Aldo C Zamudio; Oscar A Candia
Journal:  Exp Eye Res       Date:  2013-04-02       Impact factor: 3.467

10.  Retinal and Optic Disc Vascular Changes in Patients Using Long-Term Tadalafil: A Prospective Non-Randomized Matched-Pair Study.

Authors:  Marco Capece; Daniela Montorio; Chiara Comune; Achille Aveta; Alberto Melchionna; Giuseppe Celentano; Ciro Imbimbo; Felice Crocetto; Gianluigi Califano; Gilda Cennamo
Journal:  Diagnostics (Basel)       Date:  2021-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.